Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,028.00    0.00 (0.00%)
Bid:
900.00
Ask:
0.00
Spread: 131.00 (14.556%)
Market Cap: £5.03b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading Update

25 Sep 2019 07:00

RNS Number : 5383N
Babcock International Group PLC
25 September 2019
 

25 September 2019

Babcock International Group PLC (Babcock or the Group)

Babcock, the aerospace and defence company, is issuing the following trading update for the period from 1 April 2019.

Trading update

Trading across the Group is in line with our expectations.

 

Our Marine sector is performing well with increased activity across our UK warship support business and strong orders across our technology businesses. The Queen Elizabeth Class (QEC) programme is nearing completion with HMS Prince of Wales leaving Rosyth for sea trials while our Type 23 frigate life extension programme continues to progress. In Australia and Canada we continued to make good progress on our submarine and surface ship sustainment programmes. In Land, we are continuing to make good progress across our Defence Support Group (DSG) business and have successfully transitioned to the new CP6 contract in Rail. We have also seen an improvement in our South African business.

 

In Nuclear, activity levels have increased across defence though the civil nuclear market remains challenging. As expected, the Magnox contract transitioned to the Nuclear Decommissioning Authority at the end of August. In Aviation, we saw the successful start of our new international businesses in Canada and Norway and have made continued progress across our military businesses. While we have seen some delays in the award of new contracts in Aviation, overall bidding activity across the sector has increased.

 

Contract awards

The Group continued to win work across all sectors in the period, with win rates in line with our targets.

 

The highlight in the period was our selection as the preferred bidder for the Type 31 general-purpose frigate programme, which will provide the UK with a fleet of five new warships for £1.25 billion. The ships will be assembled at Babcock's Rosyth facility, and involve supply chains throughout the UK. Work will begin immediately following formal contract award later this financial year, with detailed design work to start now and manufacture commencing in 2021 and concluding in 2027.

 

Expectations for the year

We confirm our full year guidance for revenue, operating profit and free cash flow as set out in May 2019, including the phasing between the first and second halves of the year, especially for cash generation. We expect the first half to reflect the phasing of previously communicated step downs1, the normal seasonality of our business and last year's phasing of Fomedec equipment sales in our Aviation business.

 

Refinancing completed

During the period, both Standard & Poor's and DBRS confirmed the Group's credit rating of BBB following their annual credit reviews. We renewed our 5-year Revolving Credit Facility of up to £775 million and issued €550 million (c.£500 million) of 8-year bonds expiring in 2027.

 

As already announced, the estimated impact of this is to increase finance costs by around £5 million in FY20 and around £7 million in FY21 and reduce finance costs by around £2 million each year in the years following.

 

ends

 

 

For further information please contact:

Babcock International Group PLC

Simon McGough

Kate Hill

Director of Investor Relations

Group Director of Communications

Tel: +44 (0)20 3823 5592

Tel: +44 (0)20 7355 5312

FTI Consulting

Andrew Lorenz, Nick Hasell

Tel: +44 (0)20 3727 1340

 

 

Conference call

A conference call for analysts and investors will be held at 08:00 (UK time) this morning, hosted by Archie Bethel (Chief Executive) and Franco Martinelli (Group Finance Director).

 

Webcast link:

www.babcockinternational.com/investors/results-and-presentations 

 

Live call:

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Replay (available for 7 days):

Standard International Access

+44 (0) 20 8196 1480

UK Toll Free

0800 633 8453

PIN

4072877#

 

A transcript will be made available at www.babcockinternational.com/investors.

 

 

Notes

1. As stated in May 2019:

a. Revenue step downs for the full year of £410 million (QEC £80 million, Magnox £256 million, exit and disposals £74 million). The first half impact is expected to be around £150 million.

b. Operating profit step downs for the full year of £63 million (QEC £2 million, Magnox £24 million, Holdfast £17 million, exits and disposals £10 million and Brexit-related Aviation restructuring costs of £10 million). The first half impact is expected to be around £35 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEMFALFUSEEU
Date   Source Headline
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.